213 related articles for article (PubMed ID: 21906915)
1. Clozapine resistance: augmentation strategies.
Porcelli S; Balzarro B; Serretti A
Eur Neuropsychopharmacol; 2012 Mar; 22(3):165-82. PubMed ID: 21906915
[TBL] [Abstract][Full Text] [Related]
2. [Augmentation strategies in patients with schizophrenia who show partial response to clozapine treatment].
Vayısoğlu S; Anıl Yağcıoğlu E
Turk Psikiyatri Derg; 2014; 25(3):201-11. PubMed ID: 25219694
[TBL] [Abstract][Full Text] [Related]
3. Risperidone augmentation of clozapine: a critical review.
Kontaxakis VP; Ferentinos PP; Havaki-Kontaxaki BJ; Paplos KG; Pappa DA; Christodoulou GN
Eur Arch Psychiatry Clin Neurosci; 2006 Sep; 256(6):350-5. PubMed ID: 16900439
[TBL] [Abstract][Full Text] [Related]
4. Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine.
Muscatello MR; Bruno A; De Fazio P; Segura-Garcia C; Pandolfo G; Zoccali R
Expert Opin Pharmacother; 2014 Nov; 15(16):2329-45. PubMed ID: 25284216
[TBL] [Abstract][Full Text] [Related]
5. Adjunctive treatment with risperidone in clozapine-resistant schizophrenia: a case report and review.
Lerma-Carrillo I; Molina JD; Cuevas-Durán T; González-Parra S; Blasco-Fontecilla H; Andrade-Rosa C; López-Muñoz F; Alamo C
Clin Neuropharmacol; 2007; 30(2):114-21. PubMed ID: 17414944
[TBL] [Abstract][Full Text] [Related]
6. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
7. Case studies of adjunctive agents in clozapine-resistant schizophrenic patients.
Kontaxakis VP; Ferentinos PP; Havaki-Kontaxaki BJ; Paplos KG; Roukas DK; Christodoulou GN
Clin Neuropharmacol; 2005; 28(1):50-3. PubMed ID: 15711437
[TBL] [Abstract][Full Text] [Related]
8. Augmentation strategies for clozapine resistance: a systematic review and meta-analysis.
Grover S; Sarkar S; Sahoo S
Acta Neuropsychiatr; 2023 Apr; 35(2):65-75. PubMed ID: 36380513
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of clozapine with another pharmacological agent: treatment for refractory schizophrenia in the 'real world'.
Pai NB; Laidlaw M; Vella SC
Acta Psychiatr Scand; 2012 Jul; 126(1):40-6. PubMed ID: 22432694
[TBL] [Abstract][Full Text] [Related]
10. Somatic augmentation strategies in clozapine resistance--what facts?
Tranulis C; Mouaffak F; Chouchana L; Stip E; Gourevitch R; Poirier MF; Olié JP; Lôo H; Gourion D
Clin Neuropharmacol; 2006; 29(1):34-44. PubMed ID: 16518133
[TBL] [Abstract][Full Text] [Related]
11. Concurrent administration of clozapine and electroconvulsive therapy in clozapine-resistant schizophrenia.
Havaki-Kontaxaki BJ; Ferentinos PP; Kontaxakis VP; Paplos KG; Soldatos CR
Clin Neuropharmacol; 2006; 29(1):52-6. PubMed ID: 16518135
[TBL] [Abstract][Full Text] [Related]
12. Non-glutamatergic clozapine augmentation strategies: a review and meta-analysis.
Veerman SR; Schulte PF; Begemann MJ; de Haan L
Pharmacopsychiatry; 2014 Nov; 47(7):231-8. PubMed ID: 25121994
[TBL] [Abstract][Full Text] [Related]
13. Effects of clozapine plus lamotrigine on phencyclidine-induced hyperactivity.
Williams HJ; Zamzow CR; Robertson H; Dursun SM
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):239-43. PubMed ID: 16303224
[TBL] [Abstract][Full Text] [Related]
14. Augmentation Strategies for Clozapine-Resistant Patients with Schizophrenia.
Chiu YH; Hsu CY; Lu ML; Chen CH
Curr Pharm Des; 2020; 26(2):218-227. PubMed ID: 31924152
[TBL] [Abstract][Full Text] [Related]
15. Risperidone augmentation of clozapine.
McCarthy RH; Terkelsen KG
Pharmacopsychiatry; 1995 Mar; 28(2):61-3. PubMed ID: 7542786
[TBL] [Abstract][Full Text] [Related]
16. Review: Combination therapy with non-clozapine atypical antipsychotic medication: a review of current evidence.
Chan J; Sweeting M
J Psychopharmacol; 2007 Aug; 21(6):657-64. PubMed ID: 17092976
[TBL] [Abstract][Full Text] [Related]
17. Clozapine and risperidone: combination/augmentation treatment of refractory schizophrenia: a preliminary observation.
Raskin S; Katz G; Zislin Z; Knobler HY; Durst R
Acta Psychiatr Scand; 2000 Apr; 101(4):334-6. PubMed ID: 10782556
[TBL] [Abstract][Full Text] [Related]
18. Randomized controlled augmentation trials in clozapine-resistant schizophrenic patients: a critical review.
Kontaxakis VP; Ferentinos PP; Havaki-Kontaxaki BJ; Roukas DK
Eur Psychiatry; 2005 Aug; 20(5-6):409-15. PubMed ID: 16171655
[TBL] [Abstract][Full Text] [Related]
19. Risperidone as an adjunct to clozapine therapy in chronic schizophrenics.
Henderson DC; Goff DC
J Clin Psychiatry; 1996 Sep; 57(9):395-7. PubMed ID: 9746446
[TBL] [Abstract][Full Text] [Related]
20. Augmentation strategies of clozapine with antipsychotics in the treatment of ultraresistant schizophrenia.
Mouaffak F; Tranulis C; Gourevitch R; Poirier MF; Douki S; Olié JP; Lôo H; Gourion D
Clin Neuropharmacol; 2006; 29(1):28-33. PubMed ID: 16518132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
